Is this you? Create Your Porfile
Avatar

David John Parker

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David John Parker is active.

Explore More

Publication

Featured researches published by David John Parker.

Organic Process Research & Development | 2007

A Concise Synthesis of a Novel Insulin-Like Growth Factor I Receptor (IGF-IR) Inhibitor†

Joel Slade; Joginder S. Bajwa; Hui Liu; David John Parker; James Vivelo; Guang-Pei Chen; John Vincent Calienni; Edwin Bernard Villhauer; Kapa Prasad; Oljan Repic; Thomas J. Blacklock

Archive | 2003

Salts of nateglinide

Paul Allen Sutton; Richard Victor Vivilecchia; David John Parker; Marilyn De. La. Cruz

Organic Process Research & Development | 2006

A practical enantioselective synthesis of a novel peptide deformylase inhibitor

Joel Slade; David John Parker; Michael J. Girgis; Martin Mueller; James Vivelo; Hui Liu; Joginder S. Bajwa; Guang-Pei Chen; Joseph Carosi; Paul Lee; Apurva Chaudhary; Dana Wambser; Kapa Prasad; Kathryn Rene Bracken; Karl Dean; Helmut Boehnke; Oljan Repic; Thomas J. Blacklock

Organic Process Research & Development | 2007

Optimization and Scale-Up of the Grandberg Synthesis of 2-Methyltryptamine

Joel Slade; David John Parker; Michael J. Girgis; Raeann Wu; and Scott Joseph; Oljan Repic

Organic Process Research & Development | 2005

A Practical Synthesis of the Dual Matrix Metalloprotease/Tumor Necrosis Factor Inhibitor MMP090

Joel Slade; James Vivelo; David John Parker; Joginder S. Bajwa; Hui Liu; Michael J. Girgis; David T. Parker; and Oljan Repič; Thomas J. Blacklock

Archive | 2007

PROCESS FOR MAKING SALTS OF N-HYDROXY-3-[4-[[[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE

Joginder S. Bajwa; David John Parker; Joel Slade

Archive | 2004

Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines

Joel Slade; James Vivelo; Guang-Pei Chen; Joginder S. Bajwa; David John Parker

Archive | 2007

Process for making a lactate salt of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide

Joginder S. Bajwa; David John Parker; Joel Slade

Archive | 2007

PROCESS FOR MAKING N-HYDROXY-3-[4-[[[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE AND STARTING MATERIALS THEREFOR

Murat Acemoglu; Joginder S. Bajwa; David John Parker; Joel Slade

Archive | 2007

Process for making starting materials for N-hydroxy-3-[4-[2-(2-methyl-1 H-indol-3-yl)-ethylaminomethyl]-phenyl]-2E-2-propenamide

Murat Acemoglu; Joginder S. Bajwa; David John Parker; Joel Slade

Explore More

Collaboration

Dive into the David John Parker's collaboration.

Top Co-Authors
Avatar

Joel Slade

Novartis

View shared research outputs
Top Co-Authors
Avatar

Joginder S. Bajwa

Novartis

View shared research outputs
Top Co-Authors
Avatar

James Vivelo

Novartis

View shared research outputs
Top Co-Authors
Avatar

Guang-Pei Chen

Novartis

View shared research outputs
Top Co-Authors
Avatar

Hui Liu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Michael J. Girgis

Novartis

View shared research outputs
Top Co-Authors
Avatar

Oljan Repic

Novartis

View shared research outputs
Top Co-Authors
Avatar

Thomas J. Blacklock

University at Buffalo

View shared research outputs
Top Co-Authors
Avatar

Murat Acemoglu

Novartis

View shared research outputs
Top Co-Authors
Avatar

Kapa Prasad

École Polytechnique

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge